tients who are endotracheally intubated for Ͼ24 hrs (4, 5) . Postextubation stridor characterized by laryngeal edema can prolong ICU stay and even increase mortality rate (6 -8) . Thus, a reliable method to predict the occurrence of postextubation stridor and a search for effective therapies are necessary to improve quality of life and reduce ICU mortality.
The endotracheal tube cuff-leak test as an indicator of endotracheal extubation is not conclusive (9 -11) . We speculated that repeated dynamic cuff leak tests over a period of time, however, might provide a reliable technique to predict and help prevent the occurrence of postextubation stridor.
A single-dose injection of corticosteroids 1 hr before extubation was not effective in treating postextubation stridor (4, 12) . Interestingly, treatment with multiple doses of corticosteroids, which has not been tested in adult patients, reduces the incidence of postextubation airway obstruction in pediatric patients (13) . In these previous studies there was no standardized protocol with respect to the administration of corticosteroids. For example, the doses used and timing for administration were very different: a dose of 100 mg of hydrocortisone sodium succinate was infused intravenously 1 hr before extubation (4) ; an intravenous bolus of 8 mg of dexamethasone was given 1 hr before extubation (12) ; and dexamethasone was given intravenously (0.5 mg/kg, maximal dose 10 mg) every 6 hrs for six doses, beginning 6 -12 hrs before extubation (13) . Also, the patient selection varied: Patients of Ͼ15 yrs with planned elective extubation were included (4); patients of Ͼ15 yrs were divided into a short period (Ͻ36 hrs) of intubation vs. a long period (Ͼ36 hrs) (12) ; or pediatric patients (Ͻ5 yrs) intubated for 48 hrs were studied.
An objective of the present study was to test whether treatment with a single or multiple injections of corticosteroids for a given time frame would have any effect in reducing the incidence of postextubation stridor using the same inclusion criteria in high-risk adult ICU patients.
MATERIALS AND METHODS
Patients. Patients were recruited from an adult medical and surgical ICU at the Chi Mei Medical Center, a teaching hospital, in Taiwan between February 2002 and July 2004. The study protocol was approved by the institu-Objective: To determine whether treatment with corticosteroids decreases the incidence of postextubation airway obstruction in an adult intensive care unit.
Design: Clinical experiment. Setting: Adult medical and surgical intensive care unit of a teaching hospital.
Patients: One hundred twenty-eight patients who were intubated for >24 hrs with a cuff leak volume <24% of tidal volume and met weaning criteria.
Interventions: Patients were randomized into a placebo group (control, n ‫؍‬ 43) receiving four injections of normal saline every 6 hrs, a 4INJ group (n ‫؍‬ 42) receiving four injections of methylprednisolone sodium succinate, or a 1INJ group (n ‫؍‬ 42) receiving one injection of the corticosteroid followed by three injections of normal saline. Cuff volume was assessed 1 hr after each injection, and extubation was performed 1 hr after the last injection. Postextubation stridor was confirmed by examination using bronchoscopy or laryngoscopy.
Measurements and Main Results: The incidences of postextubation stridor were lower both in the 1INJ and the 4INJ groups than in the control group (11.6% and 7.1% vs. 30.2%, both p < .05), whereas there was no difference between the two treated groups (p ‫؍‬ .46). The cuff leak volume increased after the second and fourth injection in the 4INJ group and after a second injection in the 1INJ group compared with the control group (both p < .05).
Conclusions 
All patients were Ͼ18 yrs of age, had been intubated Ͼ24 hrs, and met the weaning criteria defined as respiratory rate Ͻ30 breaths/ min, negative inspiratory force Ͼ25 cm H 2 O, tidal volume Ͼ5 mL/kg of ideal body weight, and rapid shallow index Ͻ105 breaths/min/L.
Exclusion criteria were any treatment with corticosteroids 1 wk before extubation (n ϭ 164), nasal or throat disease/surgery (n ϭ 9), gastrointestinal bleeding (n ϭ 33), hyperglycemia (blood sugar Ͼ250 mg%, n ϭ 19), acute cardiac attack and cardiac surgery (n ϭ 36), or history of extubation during the same hospitalization course (n ϭ 78). The reason to exclude patients with gastrointestinal bleeding or hyperglycemia was to better distinguish between underlying diseases and steroidsinduced complications if any.
Auscultation Cuff-Leak Test. Auscultation cuff-leak and cuff-leak volume were examined and classified into three categories: a) no leak, where no sound of leak was heard by using stethoscope detection; b) mild leak, where a leak was heard using a stethoscope; and c) significant leak, where the sound of a leak was heard without using a stethoscope.
Cuff Leak Volume. The actual tidal volume at expiration was measured before and after deflation of the endotracheal tube cuff as previously described (9) . The difference in the actual tidal volume before and after cuff deflation was defined as the cuff leak volume (CLV).
Mechanical Ventilation. The patients were mechanically ventilated in a volume assistcontrol mode (Puritan-Bennett 7200 AE, Carlsbad, CA, or Bird 8400, Palm Springs, CA). The tidal volume was set at 8 mL/kg ideal body weight with respiratory rate 20 breaths/min and zero positive end-expiratory pressure during CLV measurement.
Protocol. Patients with a CLV Ն24% of tidal volume during inflation were the time matching control arm for 48 hrs after extubation (nonintervention arm). This cutoff point was set based on a previous report where 13 of 110 patients who had CLVs ranging from 0% to 24% developed postextubation stridor (9) .
Patients who had a CLV Ͻ24% of tidal volume during inflation were considered at high risk to develop postextubation stridor (9, 10) and were included in the randomized, double-blinded, and placebo-controlled clinical trial (intervention arm). The randomization procedure was carried out with random numbers. The placebo and methylprednisolone had an identical volume and appearance and were packaged in an identical manner by a respiratory therapist who was not involved in the trial. Neither the physician who prescribed the drug nor the staff who administered the infusion were aware of the intervention treatment of infusion fluid.
These patients were divided into three groups: The 4INJ group received intravenous infusion of methylprednisolone sodium succinate (Pharmacia Upjohn, Kalamazoo, MI) at 40 mg in 2 mL of normal saline every 6 hrs over 24 hrs; the 1INJ group received one infusion of methylprednisolone sodium succinate followed by three injections of normal saline every 6 hrs over 24 hrs; and a placebo group received intravenous infusion of normal saline in 2 mL every 6 hrs over 24 hrs before extubation.
Extubation was performed 1 hr after the last injection of intervention fluid. Cuff leak volume was not used as a criterion for extubation but was used afterward for data analysis. Patients were monitored for 48 hrs after extubation. The clinical stridor symptom was defined by the presence of an audible highpitched wheeze associated with respiratory distress requiring medical intervention (10, 14, 15) . Epinephrine inhalation and, in case of failure in response to three doses of epinephrine inhalation, bilevel positive airway pressure (Respironics, Murrysville, PA) were given to treat stridor, and reintubation was performed in patients who were not improved under epinephrine inhalation or/and bilevel positive airway pressure treatment. In the intervention arm, only patients with stridor underwent either bronchoscopy or laryngoscopy to further identify the occurrence of laryngeal edema by an in-charge physician during reintubation.
The patients in the nonintervention arm underwent extubation immediately after the cuff-leak test. In patients of the intervention arm, extubation was performed 1 hr after the last injection of drug or placebo saline depending on the study protocol enrolled.
Statistics. Patient characteristics were analyzed using the unpaired Student's t-test for continuous variables. Fisher's exact test was used for analysis of categorical variables. To estimate the risk of developing postextubation stridor, logistic regression analysis was applied. In univariate analysis, crude odds ratio and a 95% confidence interval of odds ratio was estimated for each risk factor we studied. A forward stepwise method was then used to construct the best final model, which includes the risk factors significantly correlated to developing stridor and leaves out those do not improve the model. In multivariate analysis, an independent effect of each risk factor was estimated with adjusted odds ratio and 95% confidence interval. To find an optimal cutoff value of CLV predictive of postextubation stridor, a receiver operating characteristic curve was used. We considered p Ͻ .05 to be statistically significant.
RESULTS
Nonintervention Arm. A total of 334 patients were included for the cuff-leak test; 13 patients were withdrawn due to deterioration of clinical conditions resulting in a delayed extubation (n ϭ 12) or selfextubation (n ϭ 1). Thus, 321 patients were enrolled in the study protocol (Fig. 1) . Of 321 patients, 193 patients who had a CLV Ն24% of tidal volume during inflation served as a nonintervention arm. The cutoff of 24% was based on the study by Sandhu and coworkers (9) . The other 128 patients with a CLV Ͻ24% served as an intervention arm and were randomized into a placebo group (n ϭ 43), a 4INJ group (n ϭ 42), or a 1INJ group (n ϭ 43). The incidence of postextubation stridor was 2.6% in the nonintervention arm and 30.2% in the placebo group of the intervention arm. This suggests that the cutoff point of 24% of CLV reliably predicts the development of postextubation stridor in this population of ICU patients.
To identify the critical point of CLV in predicting the development of postextubation stridor, we retrospectively prepared and analyzed a receiver operating characteristic curve and found that 18% was the best predictor in our patient population in the present study (Fig. 2) . There was an excellent agreement between the auscultation cuff-leak test and the CLV (Fig. 3) .
Since the robustness of a multivariate logistic model depends on the inclusion of all relevant variables, we particularly examined if the level of training of the operator to intubate patients was a significant risk factor to cause postextubation stridor. It appeared that residents were the most frequent operators of intratracheal intubation compared with attending physicians and anesthesiologists, but there was no difference with respect to the background training of operators before patient randomization into treated and nontreated groups (Table 1) .
A number of other variables including the use of sedation, Glasgow Coma Scale (GCS), Acute Physiology and Chronic Health Evaluation II score, gender, and age were analyzed to identify the most sensitive risk factors contributing to the development of postextubation stridor. It is suggested that nonsedation treatment, low GCS score, and being female were risk factors to develop postextubation stridor in the untreated patients (n ϭ 236, including patients in the nonintervention arm [n ϭ 193] and the control group [n ϭ 43] in the intervention arm) ( Table 2 ).
Intervention Arm. The patients were similar in age, gender, Acute Physiology and Chronic Health Evaluation II score, duration of intubation, endotracheal tube size, and types of ICU (medical vs. surgical) where the patients were treated (Table 1) .
In the placebo group, approximately a 4% increase from baseline in CLV was observed at 24 hrs. In the groups treated with methylprednisolone, a significant increase from baseline in CLV was seen after the second and the fourth injection (both p Ͻ .05) in the 4INJ group and after the second injection in the 1INJ group (p Ͻ .05, Fig. 4) .
We found that 18% of CLV was the optimal predictor for stridor development; we then analyzed the frequency of increased CLV Ͼ18% from baseline after each injection of methylprednisolone, although the decision of extubation was not based on the values of measured CLV. 
Figure 3. Relationship between auscultation cuffleak test and cuff leak volume (%).
No leak, no sound of leak was heard by using stethoscope detection; mild leak, leak was heard by using stethoscope; large leak, sound of leak was heard without using stethoscope. *p ϭ .007, small leak vs. no leak; p Ͻ .001, large leak vs. small leak and no leak. OR, odds ratio; CI, confidence interval; GCS, Glasgow Coma Scale; ICU, intensive care unit; APACHE, Acute Physiology and Chronic Health Evaluation.
Data from the untreated patients of the nonintervention arm (n ϭ 193) and the control group of the intervention arm (n ϭ 43).
As many as 19% patients had increased CLV Ͼ18% 12 hrs after treatment in the 1INJ group, and 40 -60% of patients showed increased CLV Ͼ18% during a prolonged treatment in the 4INJ group (Table 3) .
The changes in CLV were consistent with the incidence of postextubation stridor. As many as 30.2% of patients developed postextubation stridor in the placebo group compared with an incidence as low as 7.1% and 11.6% in the 4INJ group and the 1INJ group, respectively (both p Ͻ .05, Fig. 5 ). The rate of reintubation was 18.6% (eight of 43) in the placebo group compared with 7.1% (three of 42) in the 4INJ group and 4.7% (two of 43) in the 1INJ group (both p Ͻ .05). Neither the CLV nor the incidence of postextubation stridor was different between the two treated groups (Fig. 1) .
Since a low GCS was associated with an increased risk of stridor, one may be concerned that exposure of this population of patients to the present protocol could place them at a risk of inhalation. Importantly, our data showed no difference in the lengths of ICU stay and hospital stay between the small size groups of patients with low and high GCS on completion of the study protocol (Table 4) .
DISCUSSION
Endotracheal intubation is a useful approach to manage critically ill patients who may or may not require mechanical ventilation. However, this intervention may induce laryngeal mucosa trauma as a result of mucosa abrasion and necrosis secondary to compression, which leads to postextubation stridor (2, 3, 16, 17) . Histologic findings of postextubation stridor are characterized with mucosal inflammation, mucosal ulceration, and edema (18) . Corticosteroids have been used in infants and children to prevent or reduce postextubation stridor by suppressing mucosal inflammation including inhibition of leukocyte migration, maintenance of cell membrane integrity, attenuation of lysosome release, and reduction of fibroblast proliferation (19, 20) and tissue swelling (21) . However, intravenous infusion of ␤-methasone had no protective effect in attenuation of postextubation inflammation in pediatric ICU (22) . In experimental settings, dexamethasone effectively suppressed postintubation laryngeal edema in monkeys (23) .
There are few data in adult patients compared with pediatric patients with respect to the use of corticosteroids. A bolus intravenous injection of dexamethasone or hydrocortisone 1 hr before extubation failed to prevent laryngeal edema in adults (4, 12) . The discrepancies observed in these previous studies could be due to several factors including age, inclusion criteria, duration of intubation, dose, timing and length of treatment, and risk levels of developing stridor.
Cuff leak volume has been considered as a good indicator to predict the occurrence of postextubation stridor. Sandhu et al. (9) found that of 110 patients studied, all 13 patients (12%) who developed postextubation stridor had a CLV ranging from 0% to 24%. Their data are supported by the present study, where the incidence of postextubation stridor was 2.6% (five of 193 patients) if CLV was Ն24% and increased to 30.2% (13 of 43 patients) with CLV Ͻ24%. The difference (12% vs. 30%) in the incidence of postextubation stridor seen at an identical cuff leak cutoff point of Ͻ24% between the Sandhu et al. and the present study may be explained by a population difference, because only trauma patients were included in the former study and all kinds of ICU patients were included in the present study. Thus, the different inci- Control, patients received placebo; 1INJ, patients received one injection of the drug; 4INJ, patients received four injections of the drug.
Data are reported as percent patients with increase in cuff leak volume Ͼ18% from baseline (prior to injection of methylprednisolone sodium succinate). dences of postextubation stridor seen in the studies may reflect the severity of illness. Taken together, these observations suggest that examination of CLV is a useful approach to identify patients at high risk of developing postextubation stridor.
In the present study, a CLV of 18% was the best cutoff value to predict postextubation stridor based on its 85.3% of sensitivity at 18% CLV compared with 79.7% of sensitivity at 24% CLV. However, there is no significant difference in the specificity (72.2% vs. 77.8%) between the CLVs at 18% and 24%. Furthermore, although the CLV Ͼ24% is very useful in predicting the absence of stridor and CLV Ͻ24% identifies a high-risk group, 70% of control participants did not develop stridor. We speculate that this gap seen between the predicted high incidence and the actual low rate might be due to a number of potential mechanisms including secretions adherent to the outside of the endotracheal tube and differences in measurements between inspired tidal volume and inhaled tidal volume around the endotracheal tube.
Other studies reported CLVs of 10% and 12% as cutoff points to predict the development of postextubation stridor (5, 8 -10) . The difference in cutoff points among the studies may be due to differences in tidal volume used during measurement of cuff leak, as we used a tidal volume of 8 mL/kg compared with a tidal volume of 10 -12 mL/kg in other studies (5, 8 -10) . We demonstrated an excellent correlation between the measurements of auscultation cuff leak test and CLV. The former technique appears to be more convenient to perform at bedside and is without risk of developing aspiration pneumonia.
Treatment with intravenous injection of methylprednisolone sodium succinate resulted in a significant increase in CLV after the second injection both in the 4INJ group and in the 1INJ group where normal saline was used as a second injection. This observation suggests that a) a time frame of 6 -7 hrs after a single injection is required to exert the protective effect of methylprednisolone in reducing the incidence of postextubation stridor; and b) injections with either four separate doses or a single initial dose of methylprednisolone do not make any significant difference in the incidence of postextubation stridor. We do not anticipate any significant changes in respiratory mechanics over the period of cuff leak tests after each injection of methylprednisolone, since the conditions of the patients were relatively stable, where all patients met the extubation criteria before being included in the current protocol. We credit the protective effect of methylprednisolone demonstrated in the present study to two major factors: the homogeneous selection of patient population by using the cuff-leak test, and a prolonged therapy with methylprednisolone compared with previous studies by other investigators (4, 12) .
A few risk factors were identified in the present study including the use of sedation before intubation, GCS score, and gender. First, the use of sedation in advance of intubation may help reduce patients' anxiety that would have caused them to fight against intubation, resulting in vocal cord damage (24) , as the quality of endotracheal intubation can contribute to laryngeal hoarseness and vocal cord squeal (25) . Second, a low GCS score (3-8 points) was associated with a high incidence of postextubation stridor, which may result from a reduced ability to cough and a more frequent requirement of intratracheal suction. Third, consistent with our results, several other investigators also reported that female patients had a higher risk to develop stridor compared with male patients (4, 21, 26) . This may be related to anatomy, as the larynx is smaller, the mucosal coverage is thinner, and the mucosal membrane is less resistant to trauma in female than in male subjects (12, 27) .
The side effects with steroid therapy over 24 hrs are minimal (21) . In the present study there were no obvious complications such as gastrointestinal bleeding, high blood sugar, or increased risk of infection.
CONCLUSIONS
Our study reveals that the use of a cutoff point of CLV can help identify patients who have a high risk of developing postextubation stridor. Either a single or multiple injections of methylprednisolone 6 hrs before extubation can effectively reduce the incidence of postextubation stridor in critically ill adult patients.
